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Period2 (Per2) is an important component of the circadian clock. Mutation of this gene
is associated with vascular endothelial dysfunction and altered glucose metabolism.
The aim of this study is to further characterize whole body glucose homeostasis and
endothelial nitric oxide (NO) production in response to insulin in the mPer2Brdm1 mice.
We show that mPer2Brdm1 mice exhibit compromised insulin receptor activation and Akt
signaling in various tissues including liver, fat, heart, and aortas with a tissue-specific
heterogeneous diurnal pattern, and decreased insulin-stimulated NO release in the aortas
in both active and inactive phases of the animals. As compared to wild type (WT) mice,
the mPer2Brdm1 mice reveal hyperinsulinemia, hypoglycemia with lower fasting hepatic
glycogen content and glycogen synthase level, no difference in glucose tolerance and
insulin tolerance. The mPer2Brdm1 mice do not show increased predisposition to obesity
either on normal chow or high fat diet compared to WT controls. Thus, mice with Per2
gene mutation show altered glucose homeostasis and compromised insulin-stimulated
NO release, independently of obesity.
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INTRODUCTION
The master circadian clock residing in the suprachiasmatic
nucleus (SCN) of the hypothalamus and the clocks in periph-
eral tissues regulate many physiological functions including
glucose metabolism and cardiovascular functions (Albrecht,
2004). The molecular clock contains a set of core genes—Clock,
Bmal1, Cry1-2, Per1-3, and nuclear receptors (Rev-erbα, RORα)
(Albrecht, 2004). Through positive and negative transcriptional
and post-translational feedback loops, they generate an endoge-
nous rhythm of intracellular protein expression, leading to rhyth-
mic cell and tissue function that oscillates over approximately 24 h
(Albrecht, 2004).
Several lines of evidence suggest that circadian misalignment
and circadian clock gene disruption in humans and animals
impact the comorbidities of metabolic disorders and cardiovas-
cular risks such as obesity, diabetes, and atherosclerosis (Scheer
et al., 2009; Paschos and Fitzgerald, 2010; Huang et al., 2011).
These disease states are associated with chronic low grade inflam-
mation manifested by tissue macrophage infiltration and local
production of pro-inflammatory cytokines (Weisberg et al., 2003;
Xu et al., 2003; Lumeng and Saltiel, 2011). Mice with a muta-
tion in theClock or BMAL1 gene show phenotypes resembling the
metabolic syndrome, including predisposition to obesity, hyper-
glycaemia, and hyperlipidaemia (Rudic et al., 2004; Shimba et al.,
2005; Turek et al., 2005; Lamia et al., 2008). The effects of a
mutation in the Per2 gene on obesity and metabolic profiles
are, however, inconsistent and contradictory. While one study
reports that mice with a Per2 gene disruption are prone to obe-
sity (Yang et al., 2009; Grimaldi et al., 2010), a recent study using
mPer2Brdm1/Rev-Erbα−/− double mutant mice suggests that the
Per2 gene is involved in hepatic glucose metabolism engaging a
mechanism involving nuclear receptors (Schmutz et al., 2010).
However, whether mice with a Per2 gene mutation alone exhibit
altered whole body glucose homeostasis and insulin responses has
not been reported.
Besides regulating glucose homeostasis, insulin also exerts
profound effects on vascular endothelial function by enhanc-
ing the release of the vasoprotective molecule nitric oxide (NO)
through the protein kinase Akt, which phosphorylates and acti-
vates endothelial NO-synthase (eNOS) (Yu et al., 2011). Defects
of insulin signaling therefore result in insulin resistance, alter-
ations in glucose tolerance, and vascular endothelial dysfunction,
which is often seen in the metabolic syndrome, a cluster of
cardiovascular risk factors (Yu et al., 2011).
Given the contradictory results on predisposition of Per2
mutant mice to obesity (Yang et al., 2009; Grimaldi et al., 2010),
we further characterized in this study the whole body glucose
metabolic and vascular phenotypes of the Per2 mutant mice.
MATERIALS AND METHODS
MATERIALS
All chemicals including those for immunoblotting were obtained
from Sigma (Buchs, Switzerland), unless otherwise indi-
cated. Anti-Akt (#9272) and phospho-Akt-Ser473 (#9271), and
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anti-glycogen synthase (#3886) were from Cell Signaling; anti-
IRβ (sc-711) and phospho-IRβ-Tyr1162/1163 were from Santa
Cruz Biotechnology, Inc., Alexa Fluor680-conjugated anti-mouse
IgG (A21057) were from Molecular Probes/Invitrogen (Lucerne,
Switzerland); IRDye800-conjugated anti-rabbit IgG (926-32211)
were from LI-COR Biosciences (Bad Homburg, Germany); 4,5-
diaminofluoresceine acetate (DAF-2DA) was from VWR interna-
tional SA (Dietikon, Switzerland).
ANIMALS
The mPer2Brdm1 mutant mice were generated and propagated as
previously described (Zheng et al., 1999). Briefly, mice were bred
from pairs heterozygous for Per2Brdm1 in mixed background of
C57BL/6, 129SvEvBrd strains. All animals were maintained in a
temperature and humidity-controlled facility (temperature: 22 ±
1◦C; humidity: 55 ± 5%) with a 12-h light–dark cycle (LD12:12
cycle) and fed ad libitum with normal chow (NC; energy con-
tent: 12% fat, 28% protein, and 60% carbohydrate; UAR, Epinay
sur Orge, France). For the study, age matched (5–8 months) wild
type (WT) littermates and mPer2Brdm1 male mice were used.
Before experiments, food was removed for six hours. Mice were
sacrificed either at Zeitgeber time (ZT9) (9 h after lights on)
or at ZT15 (3 h after lights off). To study susceptibility of the
animals to obesity, the WT and mPer2Brdm1 mutant mice were
fed a high fat diet (HFD; composition: 55% fat, 21% pro-
tein, and 24% carbohydrate; Harlan Teklad TD 93075; Horst,
Netherlands) starting at the age of 12 week old for 10 weeks.
Body weight was measured weekly. Animal experimental proto-
cols were approved by the Ethical Committee of Veterinary Office
of Fribourg (A178/07), Switzerland. To measure blood glucose
concentrations under fasting and refeeding conditions, the WT
and mPer2Brdm1 mice were food deprived for 6 h followed by
refeeding with normal chow for 90min. Blood glucose levels were
then measured with a One-Touch Glucose Monitoring System
Ascensia Contour (Bayer) under the fasting and refeeding con-
ditions, respectively. In another series of experiments, food intake
was measured during 3 h of refeeding in the two groups of the
mice.
INSULIN TOLERANCE TEST (ITT) AND GLUCOSE TOLERANCE
TEST (GTT)
Insulin tolerance test (ITT) and glucose tolerance test (GTT) were
performed after 6 h of fasting at ZT9 or ZT15. 0.5mU/g insulin
(Actrapid HM, Novo-Nordisk) or 1 g/kg glucose (Masuzaki et al.,
1999) was injected intraperitoneally to the age-matched WT and
mPer2Brdm1 mice for ITT or GTT, respectively. Blood glucose
levels were measured with a One-Touch Glucose Monitoring
System Ascensia Contour (Bayer) at defined times. Moreover,
fasting plasma insulin concentration was measured with ELISA
by Services of the Metabolic Platform at Metabolic Evaluation
Facility (MEF), Faculty of Biology and Medicine, University of
Lausanne, Switzerland.
TISSUE INSULIN SIGNALING
Mouse thoracic aortas were isolated from both wild-type and
mPer2Brdm1 mutant mice following intraperitoneal injection of
ketamin (1.0mg/kg body weight, i.p.) plus xylazin (10mg/kg
body weight). Aortas were placed in cold Krebs-Ringer buffer
with the following composition (mmol/L): 118 NaCl, 4.7 KCl,
2.5 CaCl2, 1.2 MgSO4, 1.2KH2PO4, 25 NaHCO3, 0.026 EDTA,
and 5.0 D-glucose. The aortas were cleaned of the perivascu-
lar adipose tissue and loose connective tissue and cut into ring
segments. For analyzing insulin-stimulated signaling in the vas-
culature, the aortic segments were incubated in Krebs buffer at
37◦C aerated with 95% O2 and 5% CO2. After 30min of equi-
libration, insulin, or vehicle was added to the vascular rings
to reach a final concentration of 100 nmol/L for 5 or 20min
(Yuen et al., 2009). Aortic tissues were immediately snap-frozen
in liquid nitrogen and kept in −80◦C till use. Signal trans-
ductions stimulated by insulin in the aortas were analyzed by
immunoblotting.
To investigate the insulin signaling in other tissues, mice
were starved for 6 h and recombinant insulin (0.5mU/g of body
weight) was then injected intraperitoneally. Mice were sacrificed
5min post stimulation (Frangioudakis et al., 2005). Tissues, i.e.,
heart, liver, and epididymal adipose tissues were quickly dissected
and snap frozen in liquid nitrogen. The tissues were homogenized
and activation of insulin receptor and Akt by insulin was analyzed
by immunoblotting.
IMMUNOBLOTTING
Preparations of tissue lysates, protein determination, SDS-
PAGE and transfer of SDS gels to Immobilion-FL mem-
branes (Millipore) were performed as previously described
(Viswambharan et al., 2007). The resultant membrane was
stained with ponceau S and first incubated with the correspond-
ing primary antibody at room temperature for 2 h with gentle
agitation after blocking with 5% skimmed milk. The blot was
then further incubated with a corresponding anti-mouse (Alexa
fluor 680 conjugated) or anti-rabbit (IRDye 800 conjugated) sec-
ondary antibody. Signals were visualized using Odyssey Infrared
Imaging System (LI-COR Biosciences). The phosphorylated form
of insulin receptor-β or Akt was normalized to corresponding
ponceau signals. Quantification of the signals was performed
using NIH Image 1.62 software.
In-situ en face NITRIC OXIDE PRODUCTION IN AORTAS
Nitric oxide (NO) production in response to insulin in aortas was
assessed by in-situ en face staining of NO with the membrane-
permeable dye DAF-2DA. Briefly, mouse thoracic aortas cleaned
of perivascular tissues were equilibrated for 30min in Krebs
buffer supplemented with L-arginine (100μmol/L) at 37◦C and
aerated with 95% O2 and 5% CO2. DAF-2DA (5μmol/L) was
then added to the buffer for 30min. The aortas were then
washed three times with fresh Krebs-Ringer buffer and stimu-
lated with insulin (1μmol/L) for 20min. The aortic rings were
then immediately fixed in cold 4% PFA solution for 30min
and carefully opened longitudinally, counterstained with DAPI
(1μg/mL, 1min) andmounted en face for endothelial layer imag-
ing. Vectashield mounting medium was used to preserve the
fluorescence. The fluorescence was analyzed in a Leica DM6000
confocal microscope within hours after preparation. DAF-2DA
was excited with 488 nm argon laser, and images were collected
at 500–535 nm emission. At least 4–5 fields were taken from each
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vessel segment. The images from DAF-2DA and DAPI staining
were quantified with Image J software (U. S. National Institutes
of Health) and results are presented as the ratio of DAF-2DA and
DAPI positive nucleus.
HEPATIC GLYCOGEN CONTENT
For the liver glycogen determination, small liver pieces were
weighed and adjusted to a final concentration of 0.1mg liver tis-
sue per μl with 2M hydrochloric acid (Schmutz et al., 2010).
Samples were sonicated and incubated for 3 h at 99◦C with con-
stant agitation to break down glycogen in glucose and glucose-6-
phosphate. After neutralization with an equal volume of 2mol/L
NaOH and 8 volumes of 100mmol/L Tris-HCl pH 7.4, glucose
levels were determined in 20μl of neutralized solution using
the glucose-hexokinase kit (Sigma-Aldrich). To visualize glyco-
gen in liver sections, 7μm-thick paraffin-embedded liver sec-
tions were stained with Periodic Acid-Schiff (PAS) reagent using
standard protocols followed by counterstaining with Mayer’s
haematoxylin solution (Sigma-Aldrich) according to the man-
ufacturer’s instruction. A part of the liver tissues from WT
and mPer2Brdm1 mice were snap frozen in liquid nitrogen and
homogenized for immunoblotting analysis of glycogen synthase
expression.
qRT-PCR OF INFLAMMATIONMARKERS IN ADIPOSE TISSUES
RNA was extracted out of high fat tissue by homogenizing the
tissue directly in TRI Reagent® RNA Isolation Reagent followed
by phase separation with chloroform, RNA precipitation with
Isopropanol and RNA washing in 75% Ethanol. First-stranded
cDNA was synthesized from 500 ng total RNA by using a
random primer and reverse transcriptase. Real-Time PCR was
performed with the IQTM SYBR Green Supermix and iCycler
system (Bio-Rad). Amplification was achieved using an initial
cycle of 95◦C for 10min, followed by 40 cycles of 95◦C for
15 s, and 60◦C for 1min. Specificity of PCR was checked by
melting curve analysis. Expression of mRNA was normalized to
the reference gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Real-time primers (f, forward; r, reverse) used to
detect expression of the corresponding murine genes were as
follows: IL-6 f: GACAACCACGGCCTTCCCTA, r: GCCTC
CGACTTGTGAAGTGGT; TNF-α f: GGCAGGTCTACTTTGG
AGTCATTGC, r: ACATTCGAGGCTCCAGTGAATTCGG;
MCP-1 f: AGCACCAGCCAACTCTCAC, r: TCTG GACCC
ATTCCTTCTTG; F4/80 f: TGGCTGCCTCCCTGACTTTC, r:
CAAGATCCCTGCCC TGCACT; CD11c f: GGAGGAGAACAGA
GGTGCTG, r: CACCTGCTCCTGACACTCAA; GAPDH f:
ACCCAGAAGACTGTGGATGG, and r: ACACATTGGGG
GTAGGAACA.
STATISTICAL ANALYSIS
Results are presented as means ± SEM. In all experiments, n
equals the number of animals. Statistical analysis was performed
with Student’s t-tests for unpaired observations, or by One-
Way ANOVA for multiple comparisons followed by Bonferroni
adjustment. A two tailed p-value smaller than 0.05 is considered
statistically significant.
RESULTS
COMPROMISED INSULIN RECEPTOR ACTIVATION
IN mPer2Brdm1
Upon intraperitoneal injection of insulin (0.5mU/g body weight,
5min), activation of insulin receptor as measured by autophos-
phorylation of the β receptor subunit at tyrosine (Tyr)-1162/1163
wasmonitored in various tissues in bothWT andmPer2Brdm1mice
(Figure 1). As compared to WT mice, the insulin receptor activa-
tion in the liver of mPer2Brdm1 mice was compromised at both
ZT9 and ZT15 (Figure 1A). The decreased insulin receptor acti-
vation was also observed in the epididymal adipose tissue of the
mPer2Brdm1 mice at ZT15 (Figure 1B) and in the heart at ZT9
(Figure 1C). In the aortas, activation of the insulin receptor by
ex vivo stimulation with insulin at 100 nmol/L for 5min was sig-
nificantly reduced in mPer2Brdm1 mice at both ZT9 and ZT15 as
compared to WT controls (Figure 1D).
COMPROMISED INSULIN STIMULATED AKT ACTIVATION
IN mPer2Brdm1
We further analysed Akt activation upon insulin stimulation in
the above mentioned tissues. In the liver ofmPer2Brdm1mice, there
was a significant decrease in Akt activation as measured by Akt-
S473 phosphorylation in response to insulin at ZT9, but not at
ZT15 as compared to theWTmice (Figure 2A). In the epididymal
adipose tissue, impaired Akt activation upon insulin stimulation
was observed at ZT15 in the mPer2Brdm1 mice (Figure 2B) and
in the heart at ZT9 (Figure 2C). In the aortas, Akt-Ser-473 phos-
phorylation level upon insulin stimulation (100 nmol/L, 5min) at
ZT9 was significantly lower in themPer2Brdm1 as compared to the
WT mice, but no significant difference was observed 20min after
insulin stimulation (Figure 3A), indicating a delayed Akt activa-
tion in aortas of mPer2Brdm1. At ZT15, the activation of Akt stim-
ulated by insulin (100 nmol/L) was significantly reduced in the
mPer2Brdm1 mice at 5 and 20min (Figure 3B). Accordingly, aor-
tic NO production in response to insulin (100 nmol/L; 20min)
as monitored by en face DAF-2DA staining in the intact aortas
was blunted in mPer2Brdm1 at both ZT9 and ZT15 time points
(Figures 3C andD).
mPer2Brdm1 MICE EXHIBIT ALTERATIONS IN GLUCOSE
HOMEOSTASIS
In the mPer2Brdm mice, 6-h fasting plasma glucose concen-
tration was significantly lower compared to the WT animals
at both ZT9 and ZT15, which was normalized after refeeding
(Figure 4A). Food intake during the refeeding was not differ-
ent between the two groups (WT: 1.5 ± 0.12, and 1.47 ± 0.17
g/3 h, n = 16 in each group). Lower fasting hepatic glycogen con-
tent and lower glycogen synthase protein level in mPer2Brdm1
were observed as compared to WT controls (Figures 4B–D).
The mPer2Brdm mice showed no significant difference in glucose
tolerance (area under the curve) and insulin tolerance at both
ZT9 and ZT15 (Figures 5A and B). The fasting plasma insulin
level at ZT15 was significantly higher in the mPer2Brdm mice as
compared to the WT littermates (Figure 5C). The same trend
was also observed at ZT9, although it did not reach statistical
significance.
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FIGURE 1 | Compromised insulin receptor activation in response to
insulin in the liver (A), epididymal adipose tissue (B), heart (C), and
aortas (D) of mPer2Brdm1 mice. Representative immunoblotting and
respective quantifications of insulin receptor β subunit phosphorylations
(Y1162/1163) upon intraperitoneal injection of insulin (0.5mU/g body
weight, 5min) at ZT9 and ZT15, respectively (n = 4−8). ∗p < 0.05 between
indicated groups. Aortas are stimulated by insulin (100nmol/L, 5min) ex vivo
at ZT9 and ZT15. The symbol “−” or “+” means without or with insulin
stimulation, respectively. ∗ = p < 0.05 and ∗∗p < 0.01 between the indicated
groups.
mPer2Brdm1 MICE SHOWNO DIFFERENCE IN HFD-INDUCED
OBESITY
WT and mPer2Brdm1 mice showed similar body weight devel-
opment on normal chow diet over 36 weeks (Figure 6A) and
obesity on high fat diet feeding (starting at the age of 12 weeks)
over 10 weeks (Figure 6B). qRT-PCR analysis of epididymal
adipose tissues obtained from high fat diet fed mice revealed
a trend of increase in several cytokine gene expression i.e.,
TNF-α, MCP-1, IL-6, and in the macrophage markers F4/80 and
CD11c in the mPer2Brdm1 mice as compared to the WT controls
(Figure 6C).
DISCUSSION
In the present study, we show a blunted activation of the insulin
receptor upon insulin challenge in various tissues including liver,
fat, heart, and aortas of the mPer2Brdm1 mutant mice. The acti-
vation of the insulin receptor downstream signaling is affected as
evidenced by reduced or delayed Akt phosphorylation. In accor-
dance with our results, a decreased activation of Akt by vascular
endothelial growth factor in the endothelial cells has also been
reported in the mPer2Brdm1 mice (Wang et al., 2008). This has
been thought to be due to increased activity of phosphatases
that dephosphorylate Akt in these mice. Similar to mPer2Brdm1
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FIGURE 2 | Compromised Akt activation in response to insulin in the
liver (A), epididymal adipose tissue (B), and heart (C) ofmPer2Brdm1
mice. Representative immunoblotting and respective quantifications of
Akt-S473 phosphorylation upon intraperitoneal injection of insulin (0.5mU/g
body weight, 5min) at ZT9 and ZT15 (n = 7−10), respectively. The symbol
“−” or “+” means without or with insulin stimulation, respectively.
∗p < 0.05 and ∗∗p < 0.01 between the indicated groups.
mice, decreased Akt signaling has been observed in mice with
functional disruption of other circadian clock genes such as
CLOCK and BMAL1 (Anea et al., 2009). The results suggest
that insulin signaling and Akt activity are under the control of
the circadian clock. An interesting topic which remains to be
investigated is the question whether phosphatases are involved
in compromised insulin receptor activation in the mPer2Brdm1
mice.
In the vasculature, insulin stimulates NO release through Akt
(Montagnani et al., 2001), and decreased insulin-stimulated NO
release is associated with obesity (Yu et al., 2011). This represents
one of the mechanisms linking obesity to cardiovascular diseases
(Bornfeldt and Tabas, 2011). Our previous study demonstrated
that mice with a mutation in the Per2 gene exhibit impaired
endothelium-dependent relaxations in response to acetylcholine
and Ca2+-ionophores (Viswambharan et al., 2007), the agonists
that activate eNOS by Ca2+/calmodulin-dependent mechanisms.
Our present study extends these observations and we show that
the mPer2Brdm1 mice exhibit compromised vascular insulin sig-
naling linked to decreased NO production, a process that is
independent on the increase in intracellular Ca2+ concentration
mediated by Akt (Montagnani et al., 2001). The impaired acti-
vation of Akt in the aortas upon insulin stimulation reveals a
specific diurnal pattern. It is significantly decreased in the aortas
of mPer2Brdm1 mice at both ZT9 and ZT15, although the pattern
of reduced Akt activation is slightly different. The endothelial dys-
function inmPer2Brdm1 mice has been shown to be associated with
accelerated cellular senescence, impaired angiogenic capacity, and
increased susceptibility to ischemia-induced injury in the hind
limbs (Wang et al., 2008). The results from our previous study
and the present study suggest that besides an intrinsic defect of
eNOS enzymatic activation, in the mPer2Brdm1 mice, the insulin
signaling leading to eNOS activation is compromised as well.
Further experiments will focus on the elucidation of the under-
lying molecular mechanisms of insulin signaling regulated by
the Per2 gene. The effect of circadian gene mutation on vascular
endothelial function may explain circadian variation of the onset
of cardiovascular events such as myocardial infarction, sudden
cardiac death, and stroke in human populations (Muller et al.,
1985; Cohen et al., 1997).
The heart must adapt rapidly to changes in circulating energy
supply. It has been suggested that the circadian clock in the
heart is essential for cardiac gene expression, responsiveness of
the heart to energy substrates, and contractile function (Young,
2006). A recent study demonstrates that cardiac function in
mice with disruptions in circadian clock genes is significantly
attenuated under an imposed light regimen (Wu et al., 2011).
The effects of the Per2 gene on heart function are not clear.
Our previous studies showed no effects of the Per2 mutation
on ECG in mice (Viswambharan et al., 2007). The mPer2Brdm1
mice display, however, a mild cardiovascular phenotype in vitro
despite endothelial dysfunction with an elevated 24-h heart rate,
a decreased 24-h diastolic blood pressure, and an attenuation
of the dark–light difference in blood pressure and heart rate
(Vukolic et al., 2010). In the present study, we show compromised
insulin receptor activation and Akt activation in the heart of the
mPer2Brdm1 mice. The role of insulin in the heart is to regulate car-
diomyocyte energy metabolism, including fatty acid and glucose
uptake, increase cardiac efficiency (cardiac performance/oxygen
consumption) and protein synthesis, stimulate angiogenesis, sup-
press apoptosis, to promote cell survival, and increase blood
perfusion of myocardium, principally through Akt (Iliadis et al.,
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FIGURE 3 | Impaired aortic Akt activation and NO release in response to
insulin inmPer2Brdm1 mice. (A and B) Representative immunoblotting and
respective quantifications of Akt-S473 phosphorylation stimulated by insulin
(100nmol/L, 5 or 20min as indicated) at ZT9 and ZT15, respectively, in aortas
of WT and mPer2Brdm1 mice. (C and D) Confocal microscopic analysis of
insulin-stimulated NO production in aortic endothelial layer measured by
en face DAF-2DA staining followed by DAPI nucleus counterstaining at ZT9
and ZT15, respectively. The bar graph in the right panel shows the respective
quantification of NO signals. Results are presented as ratio of DAF-2DA
fluorescence intensity to DAPI (n = 4). ∗ = p < 0.05 between the indicated
groups. The symbol “−” or “+” means without or with insulin stimulation,
respectively. Bar = 200μm.
2011). The impact of the compromised insulin signaling in the
heart of the mPer2Brdm1 mice observed in our present study
under physiological and pathological conditions warrants further
investigation.
Another interesting phenotype of the mPer2Brdm1 mice
reported in this study is lower fasting hepatic glycogen content
and glycogen synthase expression, suggesting the involvement of
Per2 gene in regulation of fasting liver glycogen metabolism. The
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FIGURE 4 | Decreased fasting plasma glucose concentration and hepatic
glycogen content inmPer2Brdm1 mice. (A) Decreased fasting (F) blood
plasma glucose concentration in the mPer2Brdm1 mice as compared to WT
littermates at ZT9 and ZT15, which is normalized after refeeding (R).
(B) Fasting hepatic glycogen content of WT and mPer2Brdm1 mice at ZT9.
(C) Representative Periodic Acid-Schiff (PAS) staining showing hepatic
glycogen contents in WT and mPer2Brdm1 mice. (D) Immunoblotting showing
fasting hepatic glycogen synthase (GS) levels in WT and mPer2Brdm1 mice.
∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005 between the indicated groups,
respectively.
liver is mostly responsible for maintaining plasma glucose levels
during fasting. Under the fasting condition, the liver produces
more glucose via glycogenolysis and gluconeogenesis, which is
regulated by insulin (Peeters and Baes, 2010). The lower fasting
liver glycogen content and lower glycogen synthase levels explain
the lower fasting plasma glucose concentration in the mPer2Brdm1
mice and suggest an impaired ability of the liver to store glu-
cose in the form of glycogen. Further research should address the
question whether this is linked to compromised insulin recep-
tor activation and Akt activation in the liver of the mPer2Brdm1
mice, and how Per2 gene regulates liver glycogen metabolism. It
is to note that blood glucose levels in the mPer2Brdm1 mice after
refeeding are comparable to those in the WT mice, but remain
low after a defined glucose load (GTT). An enhanced food intake
in the mutant mice can be ruled out, since food intake during
refeeding is not different between the two groups. It is to spec-
ulate that gastrointestinal hormonal regulation mechanisms of
glucose homeostasis (Maggs et al., 2008) might be altered in the
mPer2Brdm1 mice, which requires thorough investigation.
Insulin receptor-mediated Akt signaling in insulin sensitive
tissues is crucial for glucose homeostasis (Bornfeldt and Tabas,
2011). A decrease in insulin receptor signaling mediates reduced
responsiveness of tissues or cells to insulin, i.e., insulin resis-
tance, which is central for development of metabolic syndrome
and type-II diabetes. It is accompanied by chronic low grade
inflammation manifested by inflammatory macrophage infiltra-
tion and pro-inflammatory cytokine production in adipose tis-
sues (Weisberg et al., 2003; Xu et al., 2003; Lumeng and Saltiel,
2011). To our surprise, the lower fasting plasma glucose level in
the mPer2Brdm1 mice is accompanied with higher plasma insulin
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FIGURE 5 | GTT, ITT test, and basal plasma insulin concentration inmPer2Brdm1 mice. (A) Glucose tolerance test, (B) insulin tolerance test, and (C) basal
fasting plasma insulin levels in the mPer2Brdm1 and WT mice at ZT9 and ZT15 (one blood sample from a WT mouse was lost during preparation); ∗p < 0.05 and
∗∗p < 0.01, and ∗∗∗p < 0.005 vs. mPer2Brdm1 mice.
levels and comparable insulin tolerance test and glucose toler-
ance test compared to WT control mice. These results suggest
that the lower fasting plasma glucose level in the mPer2Brdm1
mice may result from higher pancreatic insulin secretion that
compensates the reduced insulin signaling in various peripheral
insulin sensitive tissues in the Per2 mutant mice.
It is to be noted that there is a difference in the activation of
the insulin receptor or Akt among different tissues at identical
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FIGURE 6 | Body weight development and diet-induced obesity of wild type (WT) andmPer2Brdm1 mice. (A) Comparable body weight development on
chow diet and (B) obesity on high fat diet (HFD) feeding between WT and mPer2Brdm1 mice, and (C) qRT-PCR shows no significant difference in adipose tissue
inflammation markers.
ZT time point. For example, insulin receptor activation in the
mPer2Brdm1 mice is impaired at ZT9 in the liver, heart, aortas, but
not in the epididymal adipose tissue. This may be due to a tis-
sue specific insulin response profile or to tissue specific regulatory
effects of the Per2 gene on insulin responses. Furthermore, there
is a discrepancy between insulin receptor activation and Akt acti-
vation in the same tissue, e.g., activation of the insulin receptor in
the liver of mPer2Brdm1 mice is reduced at both ZT9 and ZT15,
while Akt activation is reduced only at ZT9. The underlying
mechanism is not known. Whether this is due to specific phos-
phatase activities that regulate insulin receptor activation and Akt
activation and whether it is differently affected by lack of the Per2
gene remains to be investigated. Finally, there is also a differential
activation of insulin receptor and Akt between ZT9 and ZT15.
This could be explained by the possibility that PER2 regulates the
insulin signaling pathway in a time dependent manner.
Studies from the literature with Per2 gene modified mice
reported conflicting results regarding predisposition of the mice
to obesity. A study using mPer2Brdm1 mice showed that they
are more susceptible to obesity when they are fed HFD (Yang
et al., 2009), while another study reported decreased body
weight development and adiposity (Grimaldi et al., 2010). It
is even more puzzling that the Per2−/− mouse embryonic
fibroblasts (MEF) showed increased adipocyte differentiation
(Grimaldi et al., 2010). In contrast to these studies, our present
report demonstrates that upon HFD feeding for 10 weeks, the
mPer2Brdm1 mice do not reveal any difference in body weight
gain as compared to WT control mice, suggesting that the Per2
gene mutation does not have an impact on growth develop-
ment and predisposition to obesity. Additionally, no signifi-
cant difference in obesity-associated adipose tissue inflammation
markers has been observed between obese WT and mPer2Brdm1
mice on HFD, although there is a trend of increased inflam-
mation markers in the obese mPer2Brdm1 mice. These findings
are in line with our previous observation that the mPer2Brdm1
mice exhibit no difference in food intake under normal chow
www.frontiersin.org August 2012 | Volume 3 | Article 337 | 9
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or HFD ad libitum feeding and no change in body compo-
sitions, although these mice did not show food anticipatory
activity under the condition of caloric restriction (Feillet et al.,
2006). The discrepancy between our findings and others on obe-
sity predisposition of Per2 gene disrupted mice is not clear.
It is of note that only results on female mice were reported
(Yang et al., 2009) and our study was performed in male
mice. Moreover, whether the different phenotypes of mice are
due to Per2 gene allele ablation or mutation requires further
investigation.
In conclusion, our study shows that mice with a mutation in
the circadian clock gene Per2 have compromised insulin signal-
ing, associated with lower hepatic glycogen content and decreased
vascular endothelial function, but no increased predisposition to
obesity. These results suggest a critical role of the Per2 gene in
the regulation of glucose homeostasis particularly under food
restricted conditions or in diabetes, since patients with diabetes
exhibit decreased rates of glycogen synthesis and decreased glyco-
gen contents in the liver (Krssak et al., 2004). Our study suggests
that Per2 gene could play a role in regulation of glucose home-
ostasis in diabetes particularly through the regulation of hepatic
glycogen contents.
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